On July 28, 2017, the US Food and Drug Administration (FDA) announced its intent to decrease the addictiveness of combustible cigarettes by reducing their nicotine content.
1,2 This regulatory strategy is authorized under the 2009 Family Smoking Prevention and Tobacco Control Act.
3 Emerging data suggest that reduced nicotine content (RNC) cigarettes decrease nicotine and tobacco-specific nitrosamine exposure, dependence, and daily cigarette consumption
4-12 without causing long-term compensatory behaviors.
13 Further, these products may promote cessation among treatment-seeking and non–treatment-seeking smokers.
9,11,14,15